Responses to Physical Activity Messages Among Midlife Adults
NCT ID: NCT04711512
Last Updated: 2022-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2021-04-08
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Physical Activity on Cardiovascular Risk and Quality of Life
NCT02767739
Applying Mobile Persuasive Technologies to Increase Physical Activity in Women
NCT01280812
A Text- and Audio-based Intervention to Promote Physical Activity in Midlife
NCT06172933
Effectiveness of MyPlan 2.0. in Older Adults
NCT03783611
A BCT Intervention for Physical Activity Among Individuals on Statins
NCT05273723
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will complete an initial survey to assess their global and recent experiences (e.g., demographic information, social media use). Participants then will be asked to engage in 7 days of ambulatory data collection (i.e., as they go about their normal daily activities). This includes wearing pedometers to capture PA behavior (steps per day and aerobic-intensity PA) and completing 4 surveys per day via their smartphone.
A. For the first 3 days, surveys will assess each participant's preferences and responses to potential message content as they naturally occur. Content has been pre-tested in preliminary work. This will establish participants' baseline behaviors.
B. For the following 2 days, participants will be randomized at each survey to either: 1) make an upward PA comparison (to someone engaging in a lot of activity), 2) make a downward PA comparison (to someone engaging in very little activity), or 3) assess a different experience (e.g., received social support).
C. For the final 2 days, participants will be randomized at each survey to either: 1) informational messages about ways to increase activity, 2) encouragement to increase their activity in healthy ways, or 3) reminders about their activity goals.
Phases B and C will be counterbalanced, such that half of participants will receive prompts described in Phase B before Phase C, and half will receive prompts described in Phase C before Phase B.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm (All Participants)
Within this arm, participants are randomized to one of the interventions described below at each of 4 times per day.
Encouragement/Support
Messages that focus on improving self-efficacy and motivation for physical activity
Social Comparison
Messages that provide exposure to another person's physical activity engagement data (for comparison)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Encouragement/Support
Messages that focus on improving self-efficacy and motivation for physical activity
Social Comparison
Messages that provide exposure to another person's physical activity engagement data (for comparison)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sedentary (\<150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity a week)
* One or more cardiovascular risk conditions (i.e., smoking, diagnoses of obesity. prediabetes/type 2 diabetes, prehypertension/hypertension, high cholesterol, metabolic syndrome)
* English language fluency
* Own a personal smartphone
* Have no medical or psychiatric contraindications to changing their physical activity (e.g., current injury, substance use disorder)
Exclusion Criteria
* Not sedentary (≥150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity a week)
* No health conditions listed above (smoking, diagnoses of obesity, prediabetes/type 2 diabetes, prehypertension/hypertension, high cholesterol, metabolic syndrome)
* No English language fluency
* Does not own a personal smartphone
* Has medical or psychiatric contraindications to changing their physical activity (e.g., current injury, substance use disorder)
40 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rowan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle Arigo
Role: PRINCIPAL_INVESTIGATOR
Rowan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rowan University
Glassboro, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arigo D, Schumacher LM, Baga K, Mogle JA. Digital, Social Micro-Interventions to Promote Physical Activity Among Midlife Adults With Elevated Cardiovascular Risk: An Ambulatory Feasibility Study With Momentary Randomization. Ann Behav Med. 2024 Nov 16;58(12):845-856. doi: 10.1093/abm/kaae058.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO-2020-146
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.